Researchers sought to understand how communication breakdowns occur between healthcare providers and parents of children with cancer, and how these can be improved.
Researchers sought to update and assess the interim efficacy, futility, and safety in the phase 3 SPARKLE trial.
Researchers sought to identify and analyze risk factors for thrombosis in adolescent girls receiving hormonal therapy.
Researchers sought to determine whether thromboprophylaxis may help treat patients with POTS to reduce CVC-related thrombosis.
Researchers sought to determine whether deferiprone would have the safe efficacy as deferoxamine for treating iron-overloaded patients with sickle cell disease or other transfusion-dependent anemias.
Researchers sought to determine whether conditioning chemotherapy containing alemtuzumab may improve outcomes for GVHD in pediatric patients with hematologic malignancies.
Researchers sought to determine whether LentiGlobin was safe and effective for treating a subset of patients with sickle cell disease.
Researchers sought to determine if there would be similar results for bleeding rates in pediatric patients with cancer and VTE who received either DOACs or LMWH.
Researchers sought to determine what characteristics may drive physician decisions to give immunoglobulin supplementation for patients with B-cell ALL.
